Virtu Financial’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-13,012
Closed -$247K – 2118
2019
Q1
$247K Buy
13,012
+2,117
+19% +$34.3K 0.01% 890
2018
Q4
$147K Buy
+10,895
New +$122K 0.01% 1047

Other funds holding OSIR

Virtu Financial's OSIR Position: Q2 2019 in Review

Virtu Financial sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 13,012 shares — an estimated $247K sold.

Virtu Financial first reported a position in OSIR in Q4 2018 and held it in 2 quarters. The position peaked at $247K in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

  • Virtu Financial reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Virtu Financial sold 13,012 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $247K.
  • Virtu Financial first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2018 and held it in 2 quarters.
  • Virtu Financial's Osiris Therapeutics, Inc. Common Stock position peaked at $247K in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Virtu Financial's 13F filing for Q2 2019, filed 13 Aug 2019.